Baltimore-based Cerecor announced the acquisition of Ichorion Therapeutics, a New York–based biopharmaceutical company.
The deal includes an all-stock transaction worth up to $26.6 million, with potential for an additional $15 million in milestones, which could be paid in cash or stock.
{iframe}https://technical.ly/baltimore/2018/09/25/cerecor-acquires-new-york-biopharmaceutical-company-for-26-6m-in-stock/?utm_campaign=Baltimore%20Editorial%20Email&utm_source=hs_email&utm_medium=email&utm_content=66200760&_hsenc=p2ANqtz-_IxRBt4Jzkg1PWDYX5QCyzw7p-IaWTdRCIhUHuaWIFkV9NZyA027BaEP1unG4hQGll4AHXsgHvpH2d9w6nQt3-n3ix0A&_hsmi=66200760{/iframe}